Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-923
Closed -$222K 353
2025
Q2
$222K Buy
+923
New +$215K 0.02% 264
2025
Q1
Sell
-1,508
Closed -$310K 275
2024
Q4
$310K Sell
1,508
-55
-4% -$12.1K 0.02% 227
2024
Q3
$379K Sell
1,563
-95
-6% -$22.2K 0.03% 156
2024
Q2
$364K Sell
1,658
-71
-4% -$15.4K 0.03% 149
2024
Q1
$389K Sell
1,729
-37
-2% -$8.35K 0.03% 163
2023
Q4
$388K Sell
1,766
-63
-3% -$13.3K 0.03% 170
2023
Q3
$401K Sell
1,829
-265
-13% -$59.9K 0.03% 172
2023
Q2
$471K Buy
2,094
+549
+36% +$110K 0.03% 227
2023
Q1
$296K Sell
1,545
-160
-9% -$30.9K 0.02% 312
2022
Q4
$315K Sell
1,705
-155
-8% -$27.3K 0.03% 297
2022
Q3
$309K Sell
1,860
-85
-4% -$17.3K 0.03% 289
2022
Q2
$401K Sell
1,945
-235
-11% -$53K 0.03% 257
2022
Q1
$527K Buy
+2,180
New +$505K 0.04% 234

Other funds holding STE

American Trust's STE Position: Q3 2025 in Review

American Trust sold out of Steris (STE) in Q3 2025, closing a stake of 923 shares — an estimated $222K sold.

American Trust first reported a position in STE in Q1 2022 and held it in 13 quarters. The position peaked at $527K in Q1 2022. 842 funds tracked by Wall St. Rank hold STE as of Q3 2025.

  • American Trust reported no remaining Steris position as of Q3 2025 after selling out during the quarter.
  • American Trust sold 923 Steris shares in Q3 2025, an estimated $222K.
  • American Trust first reported a position in Steris in Q1 2022 and held it in 13 quarters.
  • American Trust's Steris position peaked at $527K in Q1 2022.
  • 842 funds tracked by Wall St. Rank held Steris as of Q3 2025.

Based on American Trust's 13F filing for Q3 2025, filed 17 Nov 2025.